Drugs / Avenanthramide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06101784 Comparator | Dec 2023 → Jun 2025 | — | Montreal Heart Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Avenanthramide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06101784 ↗ |
| Known as | AVA | “Avenanthramides (AVA) are di-phenolic compounds found only in oats and are of interest due to suggested bioactivities, including antioxidant and anti-inflammatory effects in...” NCT06101784 ↗ |
| Route | Oral | “single ascending oral doses of avenanthramide” NCT06101784 ↗ |